Market Overview

Zimmer Wins FDA Clearance for iASSIST

Related ZMH
Brean Capital Cashes Out Of Zimmer Holdings, Downgrades Stock On 'Uncertainty'
Benzinga's Top Downgrades

Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market iASSIST™ Knee, the Personalized Guidance System™ for knee replacement procedures.

iASSIST represents a revolutionary next step in surgical guidance, providing simple, intuitive and accurate intraoperative feedback and alignment validation to surgeons during joint replacement procedures, eliminating the need for bulky capital equipment.  Current robotic and navigation systems use optical-tracking, requiring a clear line-of-sight into the surgical field, and rely upon complex additional equipment in the operating room, providing feedback on external computer screens. 

Posted-In: News FDA


Related Articles (ZMH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters